0.0361 USD
-0.16 (-81.12%)
0.0358 USD
0 (-0.83%)
HGEN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. Both the profitability and financial health of HGEN have multiple concerns. HGEN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- HGEN had negative earnings in the past year.
- HGEN had a negative operating cash flow in the past year.
1.2 Ratios
- The profitability ratios for HGEN are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for HGEN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- HGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- HGEN has more shares outstanding than it did 1 year ago.
- There is no outstanding debt for HGEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -232.21, we must say that HGEN is in the distress zone and has some risk of bankruptcy.
- HGEN's Altman-Z score of -232.21 is on the low side compared to the rest of the industry. HGEN is outperformed by 99.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -232.21 |
ROIC/WACCN/A
WACC11.19%
2.3 Liquidity
- A Current Ratio of 0.09 indicates that HGEN may have some problems paying its short term obligations.
- The Current ratio of HGEN (0.09) is worse than 99.66% of its industry peers.
- A Quick Ratio of 0.09 indicates that HGEN may have some problems paying its short term obligations.
- With a Quick ratio value of 0.09, HGEN is not doing good in the industry: 99.66% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.09 | ||
| Quick Ratio | 0.09 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 79.50% over the past year.
- Looking at the last year, HGEN shows a very negative growth in Revenue. The Revenue has decreased by -59.01% in the last year.
EPS 1Y (TTM)79.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
Revenue 1Y (TTM)-59.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-78.67%
3.2 Future
- The Earnings Per Share is expected to grow by 15.74% on average over the next years. This is quite good.
- HGEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 110.13% yearly.
EPS Next Y83.55%
EPS Next 2Y37.89%
EPS Next 3Y27.81%
EPS Next 5Y15.74%
Revenue Next Year-91.42%
Revenue Next 2Y-41.42%
Revenue Next 3Y165.44%
Revenue Next 5Y110.13%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- HGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year HGEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as HGEN's earnings are expected to grow with 27.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.89%
EPS Next 3Y27.81%
5. Dividend
5.1 Amount
- HGEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HUMANIGEN INC / HGEN FAQ
What is the fundamental rating for HGEN stock?
ChartMill assigns a fundamental rating of 1 / 10 to HGEN.
Can you provide the valuation status for HUMANIGEN INC?
ChartMill assigns a valuation rating of 1 / 10 to HUMANIGEN INC (HGEN). This can be considered as Overvalued.
What is the profitability of HGEN stock?
HUMANIGEN INC (HGEN) has a profitability rating of 0 / 10.
What is the earnings growth outlook for HUMANIGEN INC?
The Earnings per Share (EPS) of HUMANIGEN INC (HGEN) is expected to grow by 83.55% in the next year.